BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Suppression of inflammation in psoriasis blood after IL-17 treatment with ixekizumab

Dataset: Suppression of inflammation in psoriasis blood after IL-17 treatment with ixekizumab

The effect of anti-IL-17 treatment on systemic inflammation is not fully understand. Using cDNA microarray, genomic analysis methods such...

Registered by ArrayExpress Uploader
View Dataset

The effect of anti-IL-17 treatment on systemic inflammation is not fully understand. Using cDNA microarray, genomic analysis methods such as GSEA and ingenuity, we characterized the transcriptional changes in the blood of psoriasis patients afer systemic neutralization of IL-17 compared to baseline (before treatment). We also compared the whole blood-derived transcriptome between psoraisis patients at baseline and healthy volunteers to examine systemic inflammation in psoriasis patients. total RNA was extratced from whole blood from psoriasis patients at baseline and after two weeks of treatment; total RNA was extracted from the whole blood of healthy individuals

Species:
human

Samples:
81

Source:
E-GEOD-55201

Updated:
Dec.12, 2014

Registered:
Jul.11, 2014


Factors: (via ArrayExpress)
Sample SAMPLE GROUP SUBJECT ID SUBJECT CONDITION TIME
GSM1331534 Psoriasis treatment 1803 psoriasis patients week 2, after ixekizumab 150mg subcutaneous treatment
GSM1331533 Psoriasis treatment 1710 psoriasis patients week 2, after ixekizumab 150mg subcutaneous treatment
GSM1331532 Psoriasis treatment 1615 psoriasis patients week 2, after ixekizumab 150mg subcutaneous treatment
GSM133153 Psoriasis treatment 1611 psoriasis patients week 2, after ixekizumab 150mg subcutaneous treatment
GSM1331530 Psoriasis treatment 1209 psoriasis patients week 2, after ixekizumab 150mg subcutaneous treatment
GSM1331529 Psoriasis treatment 1208 psoriasis patients week 2, after ixekizumab 150mg subcutaneous treatment
GSM1331528 Psoriasis treatment 1207 psoriasis patients week 2, after ixekizumab 150mg subcutaneous treatment
GSM1331527 Psoriasis Baseline 1803 psoriasis patients baseline; before treatment
GSM1331526 Psoriasis Baseline 1710 psoriasis patients baseline; before treatment
GSM1331525 Psoriasis Baseline 1615 psoriasis patients baseline; before treatment
GSM1331524 Psoriasis Baseline 1611 psoriasis patients baseline; before treatment
GSM1331523 Psoriasis Baseline 1610 psoriasis patients baseline; before treatment
GSM1331522 Psoriasis Baseline 1209 psoriasis patients baseline; before treatment
GSM133152 Psoriasis Baseline 1208 psoriasis patients baseline; before treatment
GSM1331520 Psoriasis Baseline 1207 psoriasis patients baseline; before treatment
GSM1331519 Psoriasis Baseline 1902 psoriasis patients baseline; before treatment
GSM1331518 Psoriasis Baseline 1707 psoriasis patients baseline; before treatment
GSM1331517 Psoriasis Baseline 1706 psoriasis patients baseline; before treatment
GSM1331516 Psoriasis Baseline 1612 psoriasis patients baseline; before treatment
GSM1331515 Psoriasis Baseline 1609 psoriasis patients baseline; before treatment
GSM1331514 Psoriasis Baseline 1608 psoriasis patients baseline; before treatment
GSM1331513 Psoriasis Baseline 1607 psoriasis patients baseline; before treatment
GSM1331512 Psoriasis Baseline 1109 psoriasis patients baseline; before treatment
GSM13315 Psoriasis Baseline 1801 psoriasis patients baseline; before treatment
GSM1331510 Psoriasis Baseline 1606 psoriasis patients baseline; before treatment
GSM1331509 Psoriasis Baseline 1505 psoriasis patients baseline; before treatment
GSM1331508 Psoriasis Baseline 1410 psoriasis patients baseline; before treatment
GSM1331507 Psoriasis Baseline 1404 psoriasis patients baseline; before treatment
GSM1331506 Psoriasis Baseline 1403 psoriasis patients baseline; before treatment
GSM1331505 Psoriasis Baseline 1402 psoriasis patients baseline; before treatment
GSM1331504 Psoriasis Baseline 1401 psoriasis patients baseline; before treatment
GSM1331503 Psoriasis Baseline 1605 psoriasis patients baseline; before treatment
GSM1331502 Psoriasis Baseline 1504 psoriasis patients baseline; before treatment
GSM133150 Psoriasis Baseline 1502 psoriasis patients baseline; before treatment
GSM1331500 Psoriasis Baseline 1303 psoriasis patients baseline; before treatment
GSM1331499 Psoriasis Baseline 1301 psoriasis patients baseline; before treatment
GSM1331498 Psoriasis Baseline 1104 psoriasis patients baseline; before treatment
GSM1331497 Psoriasis Baseline 1102 psoriasis patients baseline; before treatment
GSM1331496 Psoriasis Baseline 1604 psoriasis patients baseline; before treatment
GSM1331495 Psoriasis Baseline 1603 psoriasis patients baseline; before treatment
GSM1331494 Psoriasis Baseline 1602 psoriasis patients baseline; before treatment
GSM1331493 Psoriasis Baseline 1601 psoriasis patients baseline; before treatment
GSM1331492 Psoriasis Baseline 1205 psoriasis patients baseline; before treatment
GSM133149 Psoriasis Baseline 1702 psoriasis patients baseline; before treatment
GSM1331490 Psoriasis Baseline 1614 psoriasis patients baseline; before treatment
GSM1331489 Psoriasis Baseline 1613 psoriasis patients baseline; before treatment
GSM1331488 Psoriasis Baseline 1507 psoriasis patients baseline; before treatment
GSM1331487 Psoriasis Baseline 1503 psoriasis patients baseline; before treatment
GSM1331486 Psoriasis Baseline 1405 psoriasis patients baseline; before treatment
GSM1331485 Psoriasis Baseline 1304 psoriasis patients baseline; before treatment
GSM1331484 Psoriasis Baseline 1108 psoriasis patients baseline; before treatment
GSM1331483 Healthy Control 11855 healthy volunteer not specified
GSM1331482 Healthy Control 11854 healthy volunteer not specified
GSM133148 Healthy Control 11853 healthy volunteer not specified
GSM1331480 Healthy Control 11852 healthy volunteer not specified
GSM1331479 Healthy Control 11851 healthy volunteer not specified
GSM1331478 Healthy Control 11850 healthy volunteer not specified
GSM1331477 Healthy Control 11849 healthy volunteer not specified
GSM1331476 Healthy Control 11848 healthy volunteer not specified
GSM1331475 Healthy Control 11847 healthy volunteer not specified
GSM1331474 Healthy Control 11846 healthy volunteer not specified
GSM1331473 Healthy Control 11824 healthy volunteer not specified
GSM1331472 Healthy Control 11823 healthy volunteer not specified
GSM133147 Healthy Control 11822 healthy volunteer not specified
GSM1331470 Healthy Control 11821 healthy volunteer not specified
GSM1331469 Healthy Control 11820 healthy volunteer not specified
GSM1331468 Healthy Control 11819 healthy volunteer not specified
GSM1331467 Healthy Control 11818 healthy volunteer not specified
GSM1331466 Healthy Control 11817 healthy volunteer not specified
GSM1331465 Healthy Control 11816 healthy volunteer not specified
GSM1331464 Healthy Control 11815 healthy volunteer not specified
GSM1331463 Healthy Control 11699 healthy volunteer not specified
GSM1331462 Healthy Control 11698 healthy volunteer not specified
GSM133146 Healthy Control 11697 healthy volunteer not specified
GSM1331460 Healthy Control 11696 healthy volunteer not specified
GSM1331459 Healthy Control 11695 healthy volunteer not specified
GSM1331458 Healthy Control 11694 healthy volunteer not specified
GSM1331457 Healthy Control 11693 healthy volunteer not specified
GSM1331456 Healthy Control 11692 healthy volunteer not specified
GSM1331455 Healthy Control 11691 healthy volunteer not specified
GSM1331454 Healthy Control 11690 healthy volunteer not specified

Tags

  • psoriasis

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use